Personalis, Inc. Common Stock

PSNLNASDAQ • USD
ThemeGenomics & Precision Med.›Genetic Testing & Diagnostics
10.75 USD
↘ 1.35 (11.16%)AT CLOSE (11:59 AM EDT)
10.89
↗ 0.14 (1.26%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
10.89
↗ 0.14 (1.26%)
🔴Market: CLOSED
Open?$11.75
High?$11.95
Low?$10.38
Prev. Close?$12.10
Volume?4.1M
Avg. Volume?2.8M
VWAP?$11.01
Rel. Volume?1.47x
Bid / Ask
Bid?$10.00 × 200
Ask?$11.00 × 400
Spread?$1.00
Midpoint?$10.50
Valuation & Ratios
Market Cap?1.3B
Shares Out?104.7M
Float?65.2M
Float %?62.3%
P/E Ratio?N/A
P/B Ratio?4.97
EPS?-$0.91
Dividend?0.00%
Ex-Dividend?N/A

Shares of Personalis, Inc. Common Stock (PSNL) are trading at $10.75. PSNL shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Themes
Healthcare - Genomics & Precision Medicine›Genetic Testing & DiagnosticsHealthcare - Oncology›Cancer Diagnostics & Biomarkers
Employees
260
Market Cap
1.3B
Industry
SERVICES-MEDICAL LABORATORIES
Website
www.personalis.com
Listed
2019-06-20
Address
6600 DUMBARTON CIRCLE
FREMONT, CA 94555
Phone: 650-752-1300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
2
Short Sent.?
51
Piotroski F-Score?0/9Weak
Altman Z-Score?14.51Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?21.08%Squeeze Risk
Short Interest?13.7M
Days to Cover?5.6
Free Float65.2M
Avg Daily Volume2.4M
Settlement Date2026-05-15
Financial Health
Current Ratio?6.61Strong
Quick Ratio?6.44Strong
Cash Ratio?1.88Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
37
4.97FAIR▾
P/S?
Peers
100
S&P
3
19.64HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-12.9CHEAP▾
EV/Sales?
Peers
100
S&P
3
18.50HIGH▾
Returns & Efficiency
ROE?
S&P
3
-37.5%WEAK▾
ROA?
S&P
3
-29.4%WEAK▾
Cash Flow & Enterprise
FCF?$-84648000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day
MarketsMoversWatchlist